Titre : Formamides

Formamides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Formamides : Questions médicales les plus fréquentes", "headline": "Formamides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Formamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-21", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Formamides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Formiates", "url": "https://questionsmedicales.fr/mesh/D005561", "about": { "@type": "MedicalCondition", "name": "Formiates", "code": { "@type": "MedicalCode", "code": "D005561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.081.420" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "N,N-Diméthyl-formamide", "alternateName": "Dimethylformamide", "url": "https://questionsmedicales.fr/mesh/D004126", "about": { "@type": "MedicalCondition", "name": "N,N-Diméthyl-formamide", "code": { "@type": "MedicalCode", "code": "D004126", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.081.420.500.387" } } } ], "about": { "@type": "MedicalCondition", "name": "Formamides", "alternateName": "Formamides", "code": { "@type": "MedicalCode", "code": "D005559", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Gang Feng", "url": "https://questionsmedicales.fr/author/Gang%20Feng", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Chemical Engineering, Chongqing University, Daxuecheng South Rd. 55, 401331 Chongqing, China." } }, { "@type": "Person", "name": "Martin Ferus", "url": "https://questionsmedicales.fr/author/Martin%20Ferus", "affiliation": { "@type": "Organization", "name": "J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, CZ 18223 Prague 8, Czech Republic." } }, { "@type": "Person", "name": "Raffaele Saladino", "url": "https://questionsmedicales.fr/author/Raffaele%20Saladino", "affiliation": { "@type": "Organization", "name": "Department of Ecological and Biological Sciences, Via San Camillo De Lellis, Università della Tuscia, Viterbo 01100, Italy." } }, { "@type": "Person", "name": "Ernesto Di Mauro", "url": "https://questionsmedicales.fr/author/Ernesto%20Di%20Mauro", "affiliation": { "@type": "Organization", "name": "Department of Ecological and Biological Sciences, Via San Camillo De Lellis, Università della Tuscia, Viterbo 01100, Italy. Electronic address: dimauroernesto8@gmail.com." } }, { "@type": "Person", "name": "Yifu Yu", "url": "https://questionsmedicales.fr/author/Yifu%20Yu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Institute of Molecular Plus, Tianjin University, Tianjin, 300072, China. yyu@tju.edu.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Coordination of CcpA and CodY Regulators in Staphylococcus aureus USA300 Strains.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36321827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/msystems.00480-22" } }, { "@type": "ScholarlyArticle", "name": "Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36047838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/pde.15017" } }, { "@type": "ScholarlyArticle", "name": "Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.", "datePublished": "2022-07-22", "url": "https://questionsmedicales.fr/article/35973315", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.diagmicrobio.2022.115772" } }, { "@type": "ScholarlyArticle", "name": "Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.", "datePublished": "2023-07-26", "url": "https://questionsmedicales.fr/article/37494330", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0287973" } }, { "@type": "ScholarlyArticle", "name": "Fucoxanthin Potentiates the Bactericidal Activity of Cefotaxime Against Staphylococcus aureus.", "datePublished": "2023-06-26", "url": "https://questionsmedicales.fr/article/37365295", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00284-023-03381-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Acides acycliques", "item": "https://questionsmedicales.fr/mesh/D000144" }, { "@type": "ListItem", "position": 5, "name": "Formiates", "item": "https://questionsmedicales.fr/mesh/D005561" }, { "@type": "ListItem", "position": 6, "name": "Formamides", "item": "https://questionsmedicales.fr/mesh/D005559" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Formamides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Formamides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Formamides", "description": "Comment diagnostiquer une exposition aux formamides ?\nQuels tests sont utilisés pour détecter les formamides ?\nQuels symptômes indiquent une intoxication aux formamides ?\nLes formamides peuvent-ils être détectés par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Staphylococcus+aureus&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Formamides", "description": "Quels sont les symptômes d'une exposition aiguë aux formamides ?\nLes formamides provoquent-ils des effets à long terme ?\nComment les formamides affectent-ils la peau ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes symptômes varient-ils selon la voie d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Staphylococcus+aureus&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Formamides", "description": "Comment prévenir l'exposition aux formamides ?\nLes travailleurs doivent-ils être formés sur les formamides ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes femmes enceintes doivent-elles éviter les formamides ?\nLes équipements de protection sont-ils obligatoires ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Staphylococcus+aureus&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Formamides", "description": "Quel est le traitement principal en cas d'intoxication aux formamides ?\nDes antidotes existent-ils pour les formamides ?\nComment traiter les irritations cutanées causées par les formamides ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition ?\nQuel suivi médical est recommandé après exposition ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Staphylococcus+aureus&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Formamides", "description": "Quelles complications peuvent survenir après exposition ?\nLes formamides peuvent-ils causer des cancers ?\nComment les formamides affectent-ils le système nerveux ?\nY a-t-il des risques pour la reproduction ?\nLes effets des formamides sont-ils réversibles ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Staphylococcus+aureus&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Formamides", "description": "Qui est le plus à risque d'exposition aux formamides ?\nLes enfants sont-ils plus vulnérables aux formamides ?\nQuels environnements augmentent le risque d'exposition ?\nLes personnes âgées sont-elles à risque ?\nLes allergies augmentent-elles le risque d'effets ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Staphylococcus+aureus&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition aux formamides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les formamides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les formamides." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication aux formamides ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des irritations cutanées." } }, { "@type": "Question", "name": "Les formamides peuvent-ils être détectés par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les formamides, mais peut montrer des effets sur les organes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux formamides." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë aux formamides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des maux de tête, des nausées et des irritations respiratoires." } }, { "@type": "Question", "name": "Les formamides provoquent-ils des effets à long terme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des problèmes neurologiques et rénaux." } }, { "@type": "Question", "name": "Comment les formamides affectent-ils la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des irritations cutanées, des rougeurs et des démangeaisons." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes similaires, mais sont plus sensibles aux effets." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la voie d'exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inhalation, l'ingestion ou le contact cutané peuvent provoquer des symptômes différents." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux formamides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les formamides ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle pour les travailleurs." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être mises en place ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Installer des systèmes de ventilation et des douches de sécurité dans les zones de travail." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter les formamides ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition aux formamides peut être nocive pour le fœtus, il faut éviter tout contact." } }, { "@type": "Question", "name": "Les équipements de protection sont-ils obligatoires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le port d'équipements de protection est obligatoire dans les environnements à risque." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication aux formamides ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à retirer la personne de l'exposition et à administrer des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les formamides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour les intoxications aux formamides." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par les formamides ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il est recommandé de rincer la zone affectée à l'eau et d'appliquer des crèmes apaisantes." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires pour l'exposition ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en cas d'exposition sévère, des soins d'urgence sont essentiels pour éviter des complications." } }, { "@type": "Question", "name": "Quel suivi médical est recommandé après exposition ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est conseillé pour surveiller les effets à long terme sur la santé." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles respiratoires, neurologiques et rénaux." } }, { "@type": "Question", "name": "Les formamides peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel entre l'exposition aux formamides et certains cancers." } }, { "@type": "Question", "name": "Comment les formamides affectent-ils le système nerveux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des troubles neurologiques, y compris des maux de tête et des vertiges." } }, { "@type": "Question", "name": "Y a-t-il des risques pour la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition aux formamides peut affecter la fertilité et le développement fœtal." } }, { "@type": "Question", "name": "Les effets des formamides sont-ils réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certains effets peuvent être réversibles, mais d'autres peuvent causer des dommages permanents." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition aux formamides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant des formamides." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux formamides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus sensibles aux effets toxiques des formamides en raison de leur développement." } }, { "@type": "Question", "name": "Quels environnements augmentent le risque d'exposition ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les environnements industriels et de laboratoire présentent un risque accru d'exposition." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques des formamides." } }, { "@type": "Question", "name": "Les allergies augmentent-elles le risque d'effets ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des allergies peuvent avoir des réactions plus sévères aux formamides." } } ] } ] }

Sources (4247 au total)

Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.

The objective of this study was to examine the occurrence, determinants, and outcome of S. aureus bloodstream infections (BSI) diagnosed based on single versus multiple positive initial cultures.... All adults with first episodes of mono-microbial S. aureus BSI in Queensland during 2000-2019 were included.... 10,855 (67%) and 5,421 (33%) were diagnosed based on one and multiple positive initial cultures, respectively. Patients with multiple positive initial cultures were significantly younger, more likely ... Among patients with S. aureus BSI, those diagnosed by single positive initial blood cultures have different clinical features and a higher risk for death....

Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.

Fluoroquinolone (FQ) is a potent antibiotic class. However, resistance to this class emerges quickly which hinders its application. In this study, mechanisms leading to the emergence of multidrug-resi... S. aureus ATCC 29213 was serially exposed to ciprofloxacin (CIP), ofloxacin (OFL), or levofloxacin (LEV) at sub-minimum inhibitory concentrations (sub-MICs) for 12 days to obtain S. aureus -1 strains ... A strong and irreversible increase of MICs was observed in all applied FQs (32 to 128 times) in all S. aureus-1 and remained 16 to 32 times in all S. aureus-2. WGS indicated 10 noticeable mutations oc... The emergence of MDR S. aureus was associated with the mutations in the FQ-target sequences and the overexpression of efflux pump systems and their regulators....

Prognostic significance of early platelet dynamics in Staphylococcus aureus bacteremia.

Platelets are recognized as key immune effectors, but they are targets of bacterial virulence factors. In the present study, we aimed to examine the relationship between early platelet dynamics and th... Electronic medical records of adult patients hospitalized for SAB between July 2012 and November 2020 were retrospectively reviewed for relevant demographic, laboratory, and clinical data. The outcome... Among the 811 patients evaluated, 29% experienced thrombocytopenia on Day 1. Platelet count nadir occurred on Days 2-3 following SAB onset, and Day 4 was a determining point of platelet count trajecto... Early platelet dynamics during SAB have prognostic significance and represent an early window for potential platelet-directed therapeutic interventions to improve outcome....

Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection.

The aim was to compare the incidence of Staphylococcus aureus bacteremia in COVID-19 and non-COVID-19 adult patients during the pandemic period versus the previous two years. Also, we described the ch... Retrospective study in our tertiary-care centre reviewing S. aureus bacteremia episodes in COVID-19 and non-COVID-19 patients through clinical records and the Microbiology Department database.... In 2018 and 2019, the incidence of S. aureus bacteremia episodes was 1.95 and 1.63 per 1000 admissions respectively. In the pandemic period, global incidence was 1.96 episodes per 1000 non-COVID-19 ad... We showed a significantly high rates of S. aureus bacteremia incidence in COVID-19 patients and higher methicillin resistance and 15-day mortality rates than in non-COVID-19 patients....

Treatment Failure in Vertebral Osteomyelitis: Is it All About Staphylococcus aureus ?

Retrospective cohort study.... The aim was to compare the influence of 2 common vertebral osteomyelitis (VO) causing pathogens on treatment failure within the first year of diagnosis.... VO is mainly caused by Staphylococcus aureus (SA), while enterococci and streptococci (ENST) are also responsible for a significant proportion of VO, particularly in elderly patients. Data on VO cause... We conducted a retrospective monocentric study including VO patients from 2008 to 2020. Primary outcome was treatment failure defined as death or relapse within 1 year (T1). We compared patients diagn... Data of 130 VO patients (SA=95; ENST=35) were available at T1. Treatment failure occurred in 37% of SA patients and 23% of ENST patients. On multivariate analysis SA [odds ratio (OR): 3.12; 95% confid... In our cohort every third patient with VO caused by SA or ENST dies within 1 year. Our findings indicate that patients with VO caused by SA, concomitant IE and/or a high Charlson comorbidity index sco...